Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00715234|
Recruitment Status : Completed
First Posted : July 15, 2008
Last Update Posted : June 25, 2013
|Condition or disease||Intervention/treatment||Phase|
|Human Papilloma Virus (HPV) Tetanus-diphtheria-acellular Pertussis (Tdap) Meningococcal Infection Varicella||Other: Reminder/recall notices for vaccines||Not Applicable|
Although patient reminder/recall systems have been shown to be effective at improving vaccination coverage levels for infants and younger children, little is known about the effectiveness of such systems for increasing immunization rates in adolescent populations. The process of reminder/recall in adolescents, and vaccination of adolescents overall, presents particular challenges. Adolescents are less likely to routinely access health care compared to younger children and adults. In addition, other obstacles such as lack of health insurance, missed opportunities for vaccination during health care visits, and the scattering of immunization records across multiple providers have posed major challenges in the vaccination of adolescents. Issues of parental consent for vaccination can also be problematic, given that adolescents may present for care without their parents accompanying them. These and other barriers to immunization may reduce the effectiveness of reminder/recall for adolescents. In the current research study, a study team with extensive experience in immunization delivery research will investigate the ability of pediatricians and family physicians in a number of different practice settings to implement a reminder/recall system for their adolescent patient populations. In addition, we will be able to examine the effectiveness of reminder/recall originating at public school-based health centers, an innovative strategy that has not previously been reported. Randomized controlled trials of reminder/recall for adolescents will be conducted at each type of site. The study team will track important process measures during reminder/recall including the percentage of the eligible population who actually received intervention; percentage with incorrect addresses; percentage with incorrect or disconnected phones; percentage actually up-to-date but incorrectly recalled; missed vaccination opportunities; and invalid doses of vaccines administered. In this way, we will be able to not only determine the degree to which reminder/recall was successful for adolescents, but also identify impediments to success, which will provide a foundation for future efforts. Our study will also investigate the cost of establishing and operating a reminder/recall system for adolescents in each type of clinical setting.
- Reminder/recall of adolescents will result in an increased rate of receipt of immunizations in private settings of approximately 10 percentage points
- Reminder/recall will result in a greater rate of receipt of immunizations when patients in public settings have access to a school-based health center (SBHC) compared to when they do not have access to a SBHC
- Reminder/recall originating at SBHC sites will result in the highest efficacy of reminder/recall among all the types of clinical sites
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||4807 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients|
|Study Start Date :||October 2007|
|Actual Primary Completion Date :||December 2009|
|Actual Study Completion Date :||September 2010|
Experimental: Reminder/recall notices for vaccines
This group will receive up to 4 recall messages (both letters and computer-generated phone messages) reminding them to get their vaccines. There are 4 separate study groups: 1) private pediatric patients 2) public pediatric patients 3) school-based health center patients and 4) family medicine patients.
Other: Reminder/recall notices for vaccines
No Intervention: Usual Care
This group will receive usual care. There are 4 separate study groups: 1) private pediatric patients 2) public pediatric patients 3) school-based health center patients and 4) family medicine patients.
- 1) the percentage receiving any vaccine after the baseline time point [ Time Frame: 6 months after intervention ]
- The percentage of adolescents becoming up-to-date on all needed immunizations [ Time Frame: 6 months post intervention ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00715234
|Principal Investigator:||Allison Kempe, MD, MPH||University of Colorado, Denver|